Literature DB >> 11460314

Mechanisms and modulation of formyl-methionyl-leucyl-phenylalanine (fMLP)-induced Ca2+ mobilization in human neutrophils.

L W Chen1, C R Jan.   

Abstract

The effect of fMLP (N-formyl-methionyl-leucyl-phenylalanine), a neutrophil-stimulating bacterial peptide, on Ca2+ mobilization in human neutrophils was examined using fura-2 as a Ca2+ indicator. fMLP (10 nM-10 microM) increased [Ca2+]i concentration-dependently. The [Ca2+]i signal comprised an initial rise followed by a gradual decay and a sustained phase. External Ca2+ removal partly decreased the signal. La3+ (50 microM) pretreatment mimicked the effect of Ca2+ removal. In Ca(2+)-free medium, pretreatment with 1 microM thapsigargin (an endoplasmic reticulum Ca2+ pump inhibitor) prevented 10 microM fMLP from increasing [Ca2+]i; whereas 1 microM thapsigargin still significantly increased [Ca2+]i after pretreatment with 10 microM fMLP. Addition of 3 mM Ca2+ induced a concentration-dependent [Ca2+]i increase after pretreatment with fMLP in Ca(2+)-free medium. This Ca2+ entry was partly inhibited by econazole (25 microM), SKF96365 (50 microM), and a phospholipase A2 inhibitor (aristolochic acid; 20 microM). The fMLP (10 microM)-induced Ca2+ release was abolished by inhibiting phospholipase C with 2 microM U73122. The fMLP-induced [Ca2+]i increase was inhibited by 25% by pretreatment with 10 nM phorbol ester to activate protein kinase C but was augmented by 27% by pretreatment with 2 microM GF 109203X to inactivate protein kinase C. We found that fMLP increase reactive oxygen intermediate (ROI) production in neutrophils, which can be suppressed by U73122 pretreatment. Collectively, this study shows that in human neutrophils, fMLP increased [Ca2+]i concentration-dependently by releasing Ca2+ from phospholipase C-coupled, thapsigargin-sensitive stores, accompanied by Ca2+ entry. The fMLP-induced [Ca2+]i rise was modulated by protein kinase C, and the fMLP-induced Ca2+ entry was abolished by La3+, and was reduced by econazole, SKF96365 and inhibition of phospholipase A2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11460314     DOI: 10.1016/s1567-5769(01)00066-2

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  Modulation of human neutrophil functions in vitro by Treponema denticola major outer sheath protein.

Authors:  Bina Puthengady Thomas; Chun Xiang Sun; Elena Bajenova; Richard P Ellen; Michael Glogauer
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

2.  Inadequate cytoplasmatic calcium signals in alveolar macrophages after cardiac surgery.

Authors:  Katharina Berger; Michael Sander; Anke Kohlar; Christian Meisel; Wolfgang Konertz; Thomas Volk
Journal:  Inflamm Res       Date:  2010-04-02       Impact factor: 4.575

3.  Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils.

Authors:  Phillip C Eckels; Anirban Banerjee; Ernest E Moore; Nathan J D McLaughlin; Lynn M Gries; Marguerite R Kelher; Kelly M England; Fabia Gamboni-Robertson; Samina Y Khan; Christopher C Silliman
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-18       Impact factor: 4.249

4.  Protein kinase C promotes restoration of calcium homeostasis to platelet activating factor-stimulated human neutrophils by inhibition of phospholipase C.

Authors:  Gregory R Tintinger; Annette J Theron; Helen C Steel; Riana Cockeran; Lynette Pretorius; Ronald Anderson
Journal:  J Inflamm (Lond)       Date:  2009-10-30       Impact factor: 4.981

5.  Abnormal neutrophil polarization in chronic obstructive pulmonary disease and how cigarette smoke extracts attract neutrophils.

Authors:  Fan Deng; Shaobo Zhong; Changhui Yu; Haijin Zhao; Hui Huang; Xiaojing Meng; Changqin Lin; Shaoxi Cai
Journal:  Ann Transl Med       Date:  2022-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.